| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 83 | 89 | 124 | 77 | | Cost of Revenue | 340 | 1,607 | 2,608 | 1,369 | | | Gross Profit | (257) | (1,518) | (2,485) | (1,292) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,885 | 1,251 | 119 | 1,670 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 300 | 331 | 780 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,442) | (3,100) | (3,384) | (2,962) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (66) | 24 | 92 | 1 | | Earnings Before Interest And Taxes | (2,508) | (3,076) | (3,292) | (2,960) | | Interest Expense | 1,705 | 1,549 | 1,470 | 1,274 | | Income Before Tax | (4,213) | (4,625) | (4,762) | (4,235) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,213) | (4,625) | (4,762) | (4,235) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,213) | (4,625) | (4,762) | (4,235) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,213) | ($4,625) | ($4,762) | ($4,235) |
|
0.11% Nasdaq 
0.12%
Income Statement
